Devyser Revenue and Competitors
Estimated Revenue & Valuation
- Devyser's estimated annual revenue is currently $22.3M per year.
- Devyser's estimated revenue per employee is $155,000
Employee Data
- Devyser has 144 Employees.
- Devyser grew their employee count by 5% last year.
Devyser's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP and General Manager, North America | Reveal Email/Phone |
2 | Head Marketing | Reveal Email/Phone |
3 | Managing Director Devyser Italia | Reveal Email/Phone |
4 | Senior Scientist product development | Reveal Email/Phone |
5 | Accountant | Reveal Email/Phone |
6 | Kontorschef | Reveal Email/Phone |
7 | Event Specialist | Reveal Email/Phone |
Devyser Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $22.3M | 144 | 5% | N/A | N/A |
#2 | $26.4M | 170 | 4% | N/A | N/A |
#3 | $3.3M | 21 | 0% | N/A | N/A |
#4 | $4.8M | 31 | 7% | N/A | N/A |
#5 | $26.4M | 170 | 4% | N/A | N/A |
#6 | $3.4M | 22 | 0% | N/A | N/A |
#7 | $18.1M | 117 | 31% | N/A | N/A |
#8 | $13.6M | 88 | -5% | N/A | N/A |
#9 | $27.3M | 176 | 21% | N/A | N/A |
#10 | $20M | 129 | 30% | N/A | N/A |
What Is Devyser?
Devyser. Results for life. We're specialists when it comes to diagnostic kits for complex DNA testing within oncology, reproductive health and hereditary diseases. Our products are used to guide targeted cancer therapies, to enable rapid prenatal diagnostics, as well as in a wide array of genetic tests. We have a guiding principle when it comes to developing products that are ideal for routine diagnostics: make the technology simple, reproducible and less prone to user-generated errors. And this is precisely what our customers appreciate about us, which is why routine diagnostic laboratories in more than 50 countries worldwide use our products.
keywords:N/A
N/A
Total Funding
144
Number of Employees
$22.3M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Devyser News
Theis joins Devyser from his most recent post as CCO at the Swedish biotechnology company Atlas Antibodies, where he was responsible for...
STOCKHOLM, April 6, 2022 /PRNewswire/ -- Devyser´s annual report 2021 has today been published on the company´s website.
Devyser is specialized in the development, manufacture, and sales of diagnostic kits. The products are sold to routine diagnostic laboratories...
Pia Gideon new Board member of Devyser Thu, Sep 30, 2021 16:30 CET Stockholm, September 30, 2021 – Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announced that Pia Gideon was elected as a new Board member at the Extraordinary General Meeting held on September 30, ...
A deep learning model, trained on thousands of mammograms, can now predict whether a person is at a high risk of developing breast cancer.
Other Companies in Stockholm
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 144 | 6% | N/A |
#2 | $26M | 145 | 25% | N/A |
#3 | $32.7M | 145 | 5% | $1.1B |
#4 | $40M | 145 | 2% | N/A |
#5 | $40.3M | 146 | 5% | N/A |